Skip to main content
. 2018 Apr 5;16:22. doi: 10.1186/s12969-018-0236-y

Table 1.

Adverse events (AEs) and serious adverse events (SAEs) under tocilizumab (TCZ)

AEs and SAEs (n = 16) under TCZ in 11/46 patients
Leukopenia 4
Recurrent infections 3
Elevated transaminases 2
Hypotonia 1
Hypertonia 1
Dyspnea 1
Abdominal pain 1
Lymphadenopathy 1
Hodgkin’s-Lymphoma 1
Gut perforation 1